Equities

Advanced Medical Solutions Group PLC

Advanced Medical Solutions Group PLC

Actions
  • Price (EUR)2.51
  • Today's Change-0.01 / -0.40%
  • Shares traded0.00
  • 1 Year change-24.05%
  • Beta0.5186
Data delayed at least 15 minutes, as of Jul 13 2020 07:02 BST.
More ▼
  • Transport

    Incoming turbulence for plane prices

    What’s set to happen in the market for passenger planes tells us a lot about the inflation dynamics over the coming years. Buckle up

Key statistics

On Monday, Advanced Medical Solutions Group PLC (AQA:FRA) closed at 2.51, 8.19% above its 52-week low of 2.32, set on Mar 23, 2020.
52-week range
Today
2.32Mar 23 20203.61Jan 07 2020
Markit short selling activity
Low
Med
High
Open2.51
High2.51
Low2.51
Bid2.49
Offer2.60
Previous close2.52
Average volume0.00
Shares outstanding215.26m
Free float201.04m
P/E (TTM)26.08
Market cap489.72m GBP
EPS (TTM)0.0872
GBP
Annual div (ADY)0.0172
EUR
Annual div yield (ADY)0.68%
Div ex-dateMay 28 2020
Div pay-dateJun 19 2020
Data delayed at least 15 minutes, as of Jul 13 2020 07:02 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.